General Principles of Pharmacology and Toxicology

Similar documents
General Principles of Pharmacology and Toxicology

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam Fall 2006

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

BASIC PHARMACOKINETICS

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

One-Compartment Open Model: Intravenous Bolus Administration:

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

PHA First Exam Fall 2003

PHARMACOKINETICS SMALL GROUP I:

Multiple IV Bolus Dose Administration

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Determination of bioavailability

Pharmacokinetics Overview

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

BIOPHARMACEUTICS and CLINICAL PHARMACY

Lippincott Questions Pharmacology

Basic Concepts of TDM

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA First Exam. Fall 2004

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Name: UFID: PHA Exam 2. Spring 2013

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Nonlinear Pharmacokinetics

PHA Spring First Exam. 8 Aminoglycosides (5 points)

Pharmacokinetics One- compartment Open Model Lec:2

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

PHAR 7633 Chapter 20 Non Compartmental Analysis

Dr. M.Mothilal Assistant professor

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

. Although there is a little

What is pharmacokinetics?

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

The general Concepts of Pharmacokinetics

PHAR 7632 Chapter 16

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

INTRODUCTION TO PHARMACOKINETICS

Winston Spencer Liauw Cancer Care Centre, St George Hospital, Gray Street, Kogarah NSW 2217, Australia

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

PHA Final Exam Fall 2001

Pharmacokinetic parameters: Halflife

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

The importance of clearance

Pharmacokinetics Applied to the Treatment of Asthma

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

Principles of Toxicokinetics/Toxicodynanics

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

Section 5.2: Pharmacokinetic properties

TDM. Measurement techniques used to determine cyclosporine level include:

PHARMACOKINETICS SMALL GROUP II:

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

PHARMACOKINETICS OF DRUG ABSORPTION

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Click to edit Master title style

AMINOGLYCOSIDES TDM D O N E B Y

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

Understand the physiological determinants of extent and rate of absorption

Case Study 2 Answers Spring 2006

Pharmacodynamics & Pharmacokinetics 1

Drug Distribution. Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Pharmacokinetics: The Basics

Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition

Introduction to Pharmacokinetics

Biomath M263 Clinical Pharmacology

General Pharmacology MCQs

Drug elimination and Hepatic clearance Chapter 6

ICU Volume 11 - Issue 3 - Autumn Series

Biopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption

Mechanisms of Drug Action

Introduction pharmacology and drug administration

DEFINITIONS. Pharmacokinetics. Pharmacodynamics. The process by which a drug is absorbed, distributed, metabolized and eliminated by the body

Renal Excretion of Drugs

Received: ; Revised; Accepted: A REVIEW ON BIOAVAILABILITY AND BIOEQUIVALENCE STUDY Shashi Kant*, Bharat Parashar

NONLINEAR PHARMACOKINETICS: INTRODUCTION

PHA First Exam Fall 2013

Volume 1(3) May-June 2013 Page 351

Pharmacokinetic and absolute bioavailability studies in early clinical development using microdose and microtracer approaches.

Brand and Generic Drugs. Educational Objectives. Absorption

PHA 5128 Spring 2009 First Exam (Version B)

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

Pharmacokinetic Calculations

Transcription:

General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

Pharmacokinetics II 2

3 Pharmacokinetics made easy! In pharmacokinetics the body is represented as a single or multiple compartments in to which the drug is distributed. Volume of Distribution = Dose/Plasma Concentration Clearance = Elimination Rate Constant x Volume of Distribution (CL = kv) Loading dose = Cp(Target) x VD Maintenance Dose = CL x CpSSav (target average steady state drug concentration)

4 Question 1 What Is the is the loading dose required for drug A if: Target concentration is 10 mg/l VD is 0.75 L/kg Patients weight is 75 kg Answer is on the next slide

5 Answer Loading Dose of Drug A VD = 0.75 L/kg x 75 kg = 56.25 L Target Conc. = 10 mg/l Loading Dose = Target Concentration x VD Loading Dose = 10 mg/l x 56.25 L = 565 mg This would probably be rounded to 560 or even 500 mg.

6 Question 2 What maintenance dose is required for drug B if: Target average SS concentration is 10 mg/l CL of drug A is 0.015 L/kg/hr Patient weighs 75 kg Answer is on the next slide

7 Answer Maintenance Dose of Drug B Maintenance Dose = CL x CpSS av CL = 0.015 L/hr/kg x 75kg = 1.125 L/hr Dose = 1.125 L/hr x 10 mg/l = 11.25 mg/hr So will need 11.25 x 24 mg per day = 270 mg

8 Half-life is the time taken for the drug concentration to fall to half its original value The elimination rate constant (k) is the fraction of drug in the body which is removed per unit time. Drug Concentration C 1 C 2 Time

9 C 0 t1/2 = 0.693/k Log Concn. C 0 /2 t 1/2 t 1/2 t 1/2 Time Time to eliminate ~ 4 t 1/2

10 Steady-state (SS) Steady-state occurs after a drug has been given for approximately five elimination half-lives. At steady-state the rate of drug administration equals the rate of elimination and plasma concentration - time curves found after each dose should be approximately superimposable. Rate in = Rate Out Reached in 4 5 half-lives (linear kinetics) Important when interpreting drug concentrations in TDM or assessing clinical response

11 Accumulation to Steady State 100 mg given every half-life 175 187.5 194 200 150 100 75 87.5 94 97 100 50

12 C Cp av t Four half lives to reach steady state

13 Elimination of a drug refers to: a) Excretion of its breakdown products in the urine b) Renal excretion of the unchanged drug c) Uptake of drug from the blood into the liver d) Metabolism of the drug in the liver e) Distribution of the drug into fat Correct answers: b, d

14 The elimination rate of a drug is: a) A constant for a particular drug and patient b) The extent to which it is excreted in urine c) Directly proportional to the plasma drug concentration d) Directly proportional to the clearance e) The extent to which the drug is excreted in the faeces Correct answers: c, d

15 Clearance: a) Depends on the elimination rate b) Refers to the efficiency of elimination of drug by an organ or the whole body c) Cannot be greater than blood flow to an organ d) Determines the steay state drug concentration during constant dosing e) Is determined by the half-life Correct answers: b, c, d

16 Two definition of clearance are: a) The volume of blood or plasma irreversibly cleared of drug per unit time b) The time taken to reduce the plasma concentration by half c) The constant relating the rate of elimination of a drug to the plasma drug concentration d) The amount of drug metabolized per unit time e) The amount of drug excreted in urine per unit time Correct answers: a, c

17 Volume of distribution is: a) The total volume of the body b) The volume of the extracellular fluid c) Equal to the volume of total body water d) The constant relating amount of drug in the body to the plasma drug concentration e) The volume of the body minus the blood volume Correct answer: d

18 The loading dose of a drug is determined by: a) The clearance b) The elimination rate c) The target plasma drug concentration d) The volume of distribution e) The molecular weight of drug Correct answers: c, d

19 The rate of distribution of a drug can determine: a) The volume of distribution b) The onset of drug effect c) The rate of drug elimination d) The duration of drug effect e) The clearance Correct answers: b, d

20 Volume of distribution can be measured using: a) The plasma drug concentration extrapolated back to zero time after administration b) The rate of elimination at a particulatr time after the dose c) The clearance d) The rate of onset of drug effect e) The duration of drug effect Correct answer: a

21 Half-life: a) Is the time taken for the plasma concentration to fall by half b) Has units of per hour c) Is the time taken for the amount of drug in the body to fall by half d) Decreases as elimination constant increases e) Increases as the elimination constant increases Correct answers: a, c, d

22 After a single dose of a drug which has a half life of 12 hours, what percentage of the dose is still in the body after 1 day? a) 87.5% b) 75% c) 50% d) 25% e) 12.5% Correct answer: d

23 During a constant rate intravenous infusion of a drug with an elimination rate constant of 0.173 per hour, the plasma drug concentration will be what percentage of steady state after 16 hours? a) 25% b) 50% c) 75% d) 87.5% e) 93.75% Correct answer: e

24 Half-life determines: a) The loading dose b) The time to reach steady state c) The drug concentration at steady state during constant dosing d) The duration of action after a single dose e) The flactuation in plasma drug concentration during a dosing interval Correct answers: b, d, e

25 Bioavailability: a) Is the extent to which a drug is absorbed from the gut b) Is the fraction of the drug metabolized first pass by liver c) Is the fraction of the dose reaching the systemic circulation intact d) Is a measure of both first-pass metabolism and absorption from the gut e) Only refers to intravenous drug administration Correct answers: c, d

26 A new generic drug is tested in a bioavailability study against the innovator brand. The AUC oral for the generic is 1200 mg*hour/l and that for the innovator brand is 1000 mg*hour/l a) The relative bioavailability of the generic formulation compared to the innovator brand is 1.2 b) The absolute bioavailability of the innovator brand is 1.0 c) The generic formulation would usually be regarded as bioequivalent to the innovator brand d) The absolue bioavailability of the innovator brand is 0.83 e) The generic brand is better than the innovator brand Correct answers: a, c

27 Which of the following routs of administration completely avoid first-pass clearance? a) Buccal b) Sublingual c) Rectal d) Oral e) Transdermal Correct answers: a, b, e

28 With respect to the renal clearance of drugs by glomerular filtration: a) Glumerular filtration rate is about 40% of renal blood flow b) Only unbound drug is filtered c) Drug clearance by glumerular filtration is equal to glomerular filtration rate d) Both bound and unbound drug can be filtered Correct answer: b

29 The proportion of drug re-absorbed from the renal tubule depends on: a) The glomerular filtration rate b) The urine flow rate c) The extent of drug secretion into the renal tubule d) The liphophilicity of the non-ionized drug e) The urine ph Correct answers: b, d, e

30 The renal clearance of a lipophilic drug which is a weak acid with a pka of 5.0 is likely to be: a) Reduced by cimetidine b) Reduced by probenecid c) Increased by acidifying the urine d) Increase by alkalinizing the urine e) Increased by an increase in urine flow rate Correct answers: b, d, e

31 The fraction of a drug unbound in plasma is: a) Usually not affected by the drug concentration b) Independent of the concentration of binding protein c) Dependent on the affinity of drug for the binding protein d) Usually increased as drug concentration increases e) Usually decreases as drug concentration increases Correct answers: a, c

32 The AUC for the plasma concentration versus time curve of a drug after a single intravenous dose is determined by: a) Volume of distribution b) Dose c) Half-life d) Clearance e) bioavailability Correct answers: b, d

33 Calculation of the volume of distribution of a drug after a single oral dose requires which of the following parameters? a) The time of max plasma concentration b) The clearance c) The elimination rate constant or half-life d) The bioavailability e) The absorption rate constant Correct answers: b, c, d

34 Explore it! Table gives plasma drug concentrations (Cp) obtained following an intravenous bolus administration of a 250 mg dose of a drug that exhibited the characteristics of a onecompartment model and was eliminated exclusively by urinary excretion. Time (h) 0.5 68.0 1.0 54.0 2.0 30.0 3.0 18.5 Plasma Con. (ug/ml) 5.0 6.0 7.0 1.8

35 Plotting the data revealed the following: a) The elimination half life (t 1/2 ) =1.275 h b) The overal elimination rate constant (K) = 0.543/h c) The intial plasma concentration (Cp) 0 = 90 ug/ml 100 Intercept = initial plasma conc. Drug conc 10 5 Slope= -K/2.303 t1/2 1 Time (h)

36 Questions a) The apparent volume of distribution (Vd)? V = Dose/(Cp) 0 b) The drug plasma concentration at 75 min following the administration of a 2.5 mg/kg dose to a subject weighting 70 kg? c) The time at which the plasma concentration of the drug will fall below 20 ug/ml, following the administration of a 275 mg dose? Cp = (Cp) 0 e Kt or Cp/(Cp) 0 = e Kt or Ln (Cp/(Cp) 0 )/-K = t

37 Answer V = Dose/(Cp) 0 V= 250/90= 2.77 L (Cp) 0 = Dose/V (Cp) 0 = 175/2.77 = 63.176 Cp = (Cp) 0 e Kt Cp = 63.176 e 0.543 x 75min or 1.25 h = 31.956 (Cp) 0 = Dose/V (Cp) 0 = 275000ug/2770 ml = 99.277 ug/ml t = Ln (Cp/(Cp) 0 )/-K t = Ln (20/99.277) 0.543 = 2.94 h

38 Take a closer look! Find more problem sets with answers in this book.

39 Take a closer look! Find more self-test questions with answers in this book.